Sarepta Therapeutics Inc

XNAS: SRPT

Expensive Underperformer

Download real time

36.43 1.16 (3.29%)

New 52W Low in past week

4.0M XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

3,580.2

Market Cap

High in industry

0.0

Beta 1Year

Very Low volatility

Sarepta Therapeutics Inc - SRPT - stock price prediction, stock price target, analyst ratings from 26 analysts

Sarepta Therapeutics Inc has a share price target of US$ 93, revenue growth forecast of 34.4%, and profit growth estimate of -198.0% for FY25, based on top 26 analyst calls.

Forecaster Screeners